Jiangsu NHWA Pharmaceutical announcement, the company recently received the Drug Administration approved Class 1 chemical drug NH160030 tablets in 4 specifications "Drug Clinical Trial Approval Notice", and will conduct clinical trials in the near future.
恩华药业：收到1类化学药品《药物临床试验批准通知书》
Jiangsu NHWA Pharmaceutical: Received a Class 1 chemical drug "Drug Clinical Trial Approval Notice".
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated